NCT02760433 · Interventional trial
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease
Overall registry status Completed
Phase 3
Conditions Rheumatoid Arthritis
Delaware Valley sites
- Arthritis Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory